chartexchange

ZVSA
ZYVERSA THERAPEUTICS INC
stockOTC

EODNov 17, 2026
0.0001USD0.000%(0.00)100
Loading…
Loading…
Healthcare
Biotechnology
HQ
Weston, FL, USA
Previous Close
$0.00
Beta
10.91
52-Week High
$0.30 2026-01-12
52-Week Low
$0.00 2026-11-17
SMA 50
$0.07
SMA 200
$0.16
Avg. Vol 10D
1,397
Avg. Vol 30D
14,934
Avg. Vol 90D
12,716
Relative Vol
0.01
4.92M
Apr 26, 2024 · 1-for-10 (reverse)
ZVSA Profile

variant pharmaceuticals is an orphan drug company leveraging advanced proprietary technologies to develop best-in-class drugs for patients with rare diseases. our accomplished leadership team, each with more than 15 years of demonstrated success in the biopharmaceutical and medical industries, focuses on assuring that our development efforts serve the needs of all our stakeholders: patients, health care providers, payors, and our investors. our evolving product pipeline is targeted to the $100+ billion orphan drug market. our lead orphan drug candidate is hydroxypropyl beta cyclodextrin (hpβcd) for chronic treatment of two orphan indications, var 200: focal segmental glomerulosclerosis (fsgs) and var 300: alport syndrome (as). both of these conditions are rare progressive forms of kidney disease associated with accumulation of cholesterol and lipids, contributing to impaired kidney function, ultimately leading to dialysis and/or kidney transplantation. hpβcd entraps and removes lipids

ZVSA Performance
PeriodPriceDateChangeBeta
1M0.002026-10-19-50.00%68.808
3M0.102026-08-18-99.90%42.296
6M0.202026-05-18-99.95%22.274
1Y0.142025-11-18-99.93%10.913
2Y1.242024-11-18-99.99%—
5Y1,578.502022-12-14-100.00%2.298
ZVSA Stock Summary

ZYVERSA THERAPEUTICS INC (OTC:ZVSA) stock price today is $0.00, and today's volume is 100. ZVSA is up 0.000% today. The 30 day average volume is 14,934. ZVSA market cap is $487 with 4.87M shares outstanding.